Justifying lipid-lowering therapy in persons ≥65 years of age

American Journal of Cardiology

Volumn 90, Issue 12, 2002, Pages 1330-1332

  LaRosa, John C ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CERIVASTATIN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; NICOTINIC ACID;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIET; DISABILITY; DRUG TOLERABILITY; FLUSHING; GROUPS BY AGE; HUMAN; ISCHEMIC HEART DISEASE; MASS SCREENING; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; RHABDOMYOLYSIS; SIDE EFFECT;

EID: 0037114824     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02872-2     Document Type: Note

References (17)

1. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497.
2. 2001 Heart and Stroke Statistical Update. 2000;American Heart Association, Dallas, Texas.
3. LaRosa J.C., He J., Vupputuri S. Effect of statins on risk of coronary disease a meta-analysis of randomized controlled trials . JAMA. 282:1999;2340-2346.
4. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals a randomized placebo-controlled trial . Lancet. 360:2002;7-22.
5. Davis B.R., Cutler J.A., Gordon D.J., Furberg C.D., Wright J.T., Cushman W.C., Grimm R.H., LaRosa J.C., Whelton P.K., Perry H.M., et al. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens. 9:1996;342-360.
6. Shepherd J., Blauw G.J., Murphy M.B., Cobbe S.M., Bollen E.L., Buckley B.M., Ford I., Jukema J.W., Hyland M., Gaw A., et al. The design of a Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Am J Cardiol. 84:1999;1192-1197.
7. Major ongoing stroke trials. Stroke. 31:2000;2536-2542.
8. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 124:1996;515-517.
9. Manolio T.A., Pearson T.A., Wenger N.K., Barrett-Conor E., Payne G.H., Harlan W.R. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol. 2:1992;161-176.
10. LaRosa J.C. Triglycerides and coronary risk in women and the elderly. Arch Intern Med. 157:1997;961-968.
11. Garry P.H., Hunt W.C., Hoehler K.M., Vander Jagt D.J., Vellas B.J. Longitudinal study of dietary intakes and plasma lipids in healthy elderly men and women. Am J Clin Nutr. 55:1992;682-688.
12. Reaven P.D., McPhillips J.B., Barrett-Connor E.L., Criqui M.H. Leisure time exercise and lipid and lipoprotein levels in an older population. J Am Geriatr Soc. 38:1990;847-854.
13. FDA Talk Paper. US Food and Drug Administration web site. Available at: http://www.fda.gov/bbs/topics/answers/2001/ans01095.html. Accessed October 26, 2001.
14. Schwartz G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., Zeiher A., Chaitman B.R., Leslie S., Stern T. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. JAMA. 285:2001;1711-1718.
15. Benner J.S., Glynn R.J., Mogun H., Neumann P.J., Weinstein M.C., Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 288:2002;455-461.
16. Anderson R.T., Ory M., Cohen S., McBride J.S. Issues of aging and adherence to health interventions. Control Clin Trials. 21:(suppl 5):2000;171S-183S.
17. Blum C.B. Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Am J Cardiol. 73:1994;3D-11D.